Functional mutations in spike glycoprotein of Zaire ebolavirus associated with an increase in infection efficiency. (13th January 2017)

• Record Type: Journal Article
• Authors: Ueda, Mahoko Takahashi; Kurosaki, Yohei; Izumi, Taisuke; Nakano, Yusuke; Oloniniyi, Olamide K.; Yasuda, Jiro; Koyanagi, Yoshio; Sato, Kei; Nakagawa, So
• Is Part Of: Genes to cells. Volume 22:Number 2(2017)
• Page Start: 148
• Page End: 159
• Publication Date: 2017-01-13
• Subjects: Cytogenetics -- Periodicals; Cells -- Mechanical properties -- Periodicals; Molecular genetics -- Periodicals; Genes -- Periodicals; Molecular biology -- Periodicals; Cytology -- Periodicals; Biomechanics -- Periodicals; 571.6
• DOI: 10.1111/gtc.12463
• Languages: English
• ISSNs: 1356-9597

Abstract

Abstract : Ebola virus (EBOV) is extremely virulent, and its glycoprotein is necessary for viral entry. EBOV may adapt to its new host humans during outbreaks by acquiring mutations especially in glycoprotein, which allows EBOV to spread more efficiently. To identify these evolutionary selected mutations and examine their effects on viral infectivity, we used experimental–phylogenetic–structural interdisciplinary approaches. In evolutionary analysis of all available Zaire ebolavirus glycoprotein sequences, we detected two codon sites under positive selection, which are located near/within the region critical for the host‐viral membrane fusion, namely alanine‐to‐valine and threonine‐to‐isoleucine mutations at 82 (A82V) and 544 (T544I), respectively. The fine‐scale transmission dynamics of EBOV Makona variants that caused the 2014–2015 outbreak showed that A82V mutant was fixed in the population, whereas T544I was not. Furthermore, pseudotype assays for the Makona glycoprotein showed that the A82V mutation caused a small increase in viral infectivity compared with the T544I mutation. These findings suggest that mutation fixation in EBOV glycoprotein may be associated with their increased infectivity levels; the mutant with a moderate increase in infectivity will fix. Our findings showed that a driving force for Ebola virus evolution via glycoprotein may be a balance between costs and benefits of its virulence. Abstract : Analyzing all available Zaire ebolavirus glycoprotein sequences, we found that A82V mutant was fixed in the 2014–2015 outbreak, whereas T544I was not, both of which are under positive selection. Pseudotype assays demonstrated that the A82V mutation caused a small increase in viral infectivity compared with the T544I mutation. Our findings suggest that a driving force for Ebola virus evolution via glycoprotein may be a balance between costs and benefits of its virulence.